CBIO
CRESCENT BIOPHARMA, INC.
NASDAQ · Healthcare · Biotechnology · US
$12.36
+4.39%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1285.48x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.81x
- Price / sales
- 38.63x
- Price / cash flow
- -6.32x
Enterprise value
- Enterprise value
- $292.9M
- EV / sales
- 24.65x
- EV / EBITDA
- -1.80x
- EV / EBIT
- -1.74x
- Market cap
- $459.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026